353 related articles for article (PubMed ID: 17686790)
1. Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption.
Amital H; Heilweil-Harel M; Ulmansky R; Harlev M; Toubi E; Hershko A; Naparstek Y
Rheumatology (Oxford); 2007 Sep; 46(9):1433-7. PubMed ID: 17686790
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
[TBL] [Abstract][Full Text] [Related]
3. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis.
Renaudineau Y; Croquefer S; Jousse S; Renaudineau E; Devauchelle V; Guéguen P; Hanrotel C; Gilburd B; Saraux A; Shoenfeld Y; Putterman C; Youinou P
Arthritis Rheum; 2006 Aug; 54(8):2523-32. PubMed ID: 16868973
[TBL] [Abstract][Full Text] [Related]
4. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
Zandman-Goddard G; Blank M; Langevitz P; Slutsky L; Pras M; Levy Y; Shovman O; Witte T; Doria A; Rovensky J; Shoenfeld Y
Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675
[TBL] [Abstract][Full Text] [Related]
5. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
8. Detection of masked anti-DNA antibodies in lupus sera by a monoclonal anti-idiotype.
Halpern R; Schiffenbauer J; Solomon G; Diamond B
J Immunol; 1984 Oct; 133(4):1852-6. PubMed ID: 6332136
[TBL] [Abstract][Full Text] [Related]
9. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
10. Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?
Mason LJ; Ravirajan CT; Rahman A; Putterman C; Isenberg DA
Arthritis Rheum; 2004 Mar; 50(3):866-70. PubMed ID: 15022329
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
Morgan PE; Sturgess AD; Davies MJ
Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
[TBL] [Abstract][Full Text] [Related]
13. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
[TBL] [Abstract][Full Text] [Related]
14. B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease.
Schett G; Dumortier H; Hoefler E; Muller S; Steiner G
Ann Rheum Dis; 2009 May; 68(5):729-35. PubMed ID: 18495733
[TBL] [Abstract][Full Text] [Related]
15. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
Williams RC; Malone CC; Meyers C; Decker P; Muller S
J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
[TBL] [Abstract][Full Text] [Related]
16. High-avidity anti-DNA antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns.
Matsuki Y; Suzuki K; Kawakami M; Ishizuka T; Kawaguchi Y; Hidaka T; Nakamura H
J Clin Apher; 1996; 11(1):30-5. PubMed ID: 8722720
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of a new quantitative enzyme-linked immunosorbent assay for detection of double-stranded DNA autoantibodies.
Bardin N; Ragot C; Sanmarco M
Ann N Y Acad Sci; 2007 Aug; 1109():511-8. PubMed ID: 17785340
[TBL] [Abstract][Full Text] [Related]
18. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
